IRCT20161210031316N2已完成3 期
Therapeutic effects of losartan in nonalcoholic steatohepatitis
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Non-alcoholic steatohepatitis and liver enzymes are based on indicators of liver function and ultrasound
- •Age over 18 years
排除标准
- •intake of angiotensin receptor antagonists
- •use of angiotensin converting enzyme inhibitors
- •resistance-resistant hypertension
- •Uncontrolled Diabetes
- •hypotension
- •serious interactions with other patient medications
- •other causes of liver steatosis
研究者
相似试验
招募中
3 期
Evaluation of the effects of Losartan in patients with corona virus disease 2019Corona virus disease 2019 (COVID-19).Coronavirus infection, unspecifiedB34.2IRCT20180802040678N4Tabriz University of Medical Sciences100
已完成
不适用
To study whether a drug (Saroglitazaar) used to treat diabetes and deranged lipid profile can lead to improvement in fatty liver alsoCTRI/2019/05/019199Dept of Gastroenterology107
已完成
3 期
Investigation Effect of losartan NAFLD patientsAFLD.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20180412039283N1Shahid Beheshti University of Medical Sciences250
已完成
2 期
Effect of Losartan in Patients With Nonobstructive Hypertrophic CardiomyopathyHypertrophic CardiomyopathyNCT01150461Massachusetts General Hospital20
已完成
不适用
The evaluation of the effect of losartan on central blood pressure via sympathetic tone and endothelial functioHypertensionJPRN-UMIN000005653The Second Department of Internal Medicine Tokyo Medical University50